All-trans retinoic acid modifies the expression of clock and disease marker genes

Journal of Nutritional Biochemistry

Volumn 23, Issue 3, 2012, Pages 209-217

  Sherman, Hadas ^a   Gutman, Roee ^a   Chapnik, Nava ^a   Meylan, Jenny ^b   le Coutre, Johannes ^b,c   Froy, Oren ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

ATRA; Circadian; Clock; Disease; Restricted feeding; Vitamin A

Indexed keywords

ARGINASE; ASPARTATE AMINOTRANSFERASE; MESSENGER RNA; RETINOIC ACID; TRANSCRIPTION FACTOR CLOCK;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CIRCADIAN RHYTHM; COLORIMETRY; CONTROLLED STUDY; DIET RESTRICTION; DISEASE MARKER; FOOD INTAKE; GENE EXPRESSION; IN VIVO STUDY; LOCOMOTION; MALE; MOUSE; NONHUMAN; OSCILLATION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; REAL TIME POLYMERASE CHAIN REACTION; VITAMIN SUPPLEMENTATION; WELLBEING; WESTERN BLOTTING;

ALPHA-FETOPROTEINS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, DIFFERENTIATION; ASPARTATE AMINOTRANSFERASES; C-REACTIVE PROTEIN; CALORIC RESTRICTION; CIRCADIAN CLOCKS; CIRCADIAN RHYTHM; CLOCK PROTEINS; GENE EXPRESSION REGULATION; GENETIC MARKERS; JEJUNUM; LIVER; MALE; MICE; MICE, INBRED C57BL; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRETINOIN;

MUS;

EID: 84856699803     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.11.017     Document Type: Article

References (74)

1. Reppert S.M., Weaver D.R. Coordination of circadian timing in mammals. Nature 2002, 418:935-941.
2. Lucas R.J., Freedman M.S., Lupi D., Munoz M., David-Gray Z.K., Foster R.G. Identifying the photoreceptive inputs to the mammalian circadian system using transgenic and retinally degenerate mice. Behav Brain Res 2001, 125:97-102.
3. Liu C., Weaver D.R., Strogatz S.H., Reppert S.M. Cellular construction of a circadian clock: period determination in the suprachiasmatic nuclei. Cell 1997, 91:855-860.
4. Herzog E.D., Takahashi J.S., Block G.D. Clock controls circadian period in isolated suprachiasmatic nucleus neurons. Nat Neurosci 1998, 1:708-713.
5. Welsh D.K., Logothetis D.E., Meister M., Reppert S.M. Individual neurons dissociated from rat suprachiasmatic nucleus express independently phased circadian firing rhythms. Neuron 1995, 14:697-706.
6. Froy O., Chapnik N. Circadian oscillation of innate immunity components in mouse small intestine. Mol Immunol 2007, 44:1954-1960.
7. Lee C., Etchegaray J.P., Cagampang F.R., Loudon A.S., Reppert S.M. Posttranslational mechanisms regulate the mammalian circadian clock. Cell 2001, 107:855-867.
8. Vitaterna M.H., King D.P., Chang A.M., Kornhauser J.M., Lowrey P.L., McDonald J.D., et al. Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science 1994, 264:719-725.
9. Froy O., Chang D.C., Reppert S.M. Redox potential: differential roles in dCRY and mCRY1 functions. Curr Biol 2002, 12:147-152.
10. Kume K., Zylka M.J., Sriram S., Shearman L.P., Weaver D.R., Jin X., et al. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell 1999, 98:193-205.
11. Hurd M.W., Ralph M.R. The significance of circadian organization for longevity in the golden hamster. J Biol Rhythms 1998, 13:430-436.
12. Hofman M.A., Swaab D.F. Living by the clock: the circadian pacemaker in older people. Ageing Res Rev 2006, 5:33-51.
13. Carapetis J.R., McDonald M., Wilson N.J. Acute rheumatic fever. Lancet 2005, 366:155-168.
14. Davis S., Mirick D.K. Circadian disruption, shift work and the risk of cancer: a summary of the evidence and studies in Seattle. Cancer Causes Control 2006, 17:539-545.
15. Filipski E., Li X.M., Levi F. Disruption of circadian coordination and malignant growth. Cancer Causes Control 2006, 17:509-514.
16. Froy O. The relationship between nutrition and circadian rhythms in mammals. Front Neuroendocrinol 2007, 28:61-71.
17. Froy O., Chapnik N., Miskin R. Long-lived alphaMUPA transgenic mice exhibit pronounced circadian rhythms. Am J Physiol Endocrinol Metab 2006, 291:E1017-E1024.
18. Karlsson B., Knutsson A., Lindahl B. Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people. Occup Environ Med 2001, 58:747-752.
19. Kondratov R.V., Kondratova A.A., Gorbacheva V.Y., Vykhovanets O.V., Antoch M.P. Early aging and age-related pathologies in mice deficient in BMAL1, the core component of the circadian clock. Genes Dev 2006, 20:1868-1873.
20. Mosendane T., Raal F.J. Shift work and its effects on the cardiovascular system. Cardiovasc J Afr 2008, 19:210-215.
21. Rudic R.D., McNamara P., Curtis A.M., Boston R.C., Panda S., Hogenesch J.B., et al. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol 2004, 2:e377.
22. Staels B. When the Clock stops ticking, metabolic syndrome explodes. Nat Med 2006, 12:54-55. [discussion 5].
23. Teboul M., Guillaumond F., Grechez-Cassiau A., Delaunay F. The nuclear hormone receptor family round the clock. Mol Endocrinol 2008, 22:2573-2582.
24. Preitner N., Damiola F., Lopez-Molina L., Zakany J., Duboule D., Albrecht U., et al. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002, 110:251-260.
25. Yang X., Downes M., Yu R.T., Bookout A.L., He W., Straume M., et al. Nuclear receptor expression links the circadian clock to metabolism. Cell 2006, 126:801-810.
26. Aranda A., Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 2001, 81:1269-1304.
27. Wolf J.E. Potential anti-inflammatory effects of topical retinoids and retinoid analogues. Adv Ther 2002, 19:109-118.
28. Shirai H., Oishi K., Ishida N. Bidirectional CLOCK/BMAL1-dependent circadian gene regulation by retinoic acid in vitro. Biochem Biophys Res Commun 2006, 351:387-391.
29. McNamara P., Seo S.B., Rudic R.D., Sehgal A., Chakravarti D., FitzGerald G.A. Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock. Cell 2001, 105:877-889.
30. Hogenesch J.B., Chan W.K., Jackiw V.H., Brown R.C., Gu Y.Z., Pray-Grant M., et al. Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway. J Biol Chem 1997, 272:8581-8593.
31. Zhou Y.D., Barnard M., Tian H., Li X., Ring H.Z., Francke U., et al. Molecular characterization of two mammalian bHLH-PAS domain proteins selectively expressed in the central nervous system. Proc Natl Acad Sci U S A 1997, 94:713-718.
32. Froy O., Chapnik N., Miskin R. The suprachiasmatic nuclei are involved in determining circadian rhythms during restricted feeding. Neuroscience 2008, 155:1152-1159.
33. Luna-Moreno D., Aguilar-Roblero R., Diaz-Munoz M. Restricted feeding entrains rhythms of inflammation-related factors without promoting an acute-phase response. Chronobiol Int 2009, 26:1409-1429.
34. Gutman R., Yosha D., Choshniak I., Kronfeld-Schor N. Two strategies for coping with food shortage in desert golden spiny mice. Physiol Behav 2007, 90:95-102.
35. Froy O., Chapnik N., Miskin R. Mouse intestinal cryptdins exhibit circadian oscillation. FASEB J 2005, 19:1920-1922.
36. Sherman H., Froy O. Expression of human beta-defensin 1 is regulated via c-Myc and the biological clock. Mol Immunol 2008, 45:3163-3167.
37. Cao S.X., Dhahbi J.M., Mote P.L., Spindler S.R. Genomic profiling of short- and long-term caloric restriction effects in the liver of aging mice. Proc Natl Acad Sci U S A 2001, 98:10630-10635.
38. Fu C., Hickey M., Morrison M., McCarter R., Han E.S. Tissue specific and non-specific changes in gene expression by aging and by early stage CR. Mech Ageing Dev 2006, 127:905-916.
39. Duffy P.H., Feuers R.J., Hart R.W. Effect of chronic caloric restriction on the circadian regulation of physiological and behavioral variables in old male B6C3F1 mice. Chronobiol Int 1990, 7:291-303.
40. Yao D.F., Dong Z.Z., Yao M. Specific molecular markers in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2007, 6:241-247.
41. Oh S.Y., Cho Y.K., Kang M.S., Yoo T.W., Park J.H., Kim H.J., et al. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism 2006, 55:1604-1609.
42. Qiu W., David D., Zhou B., Chu P.G., Zhang B., Wu M., et al. Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. Am J Pathol 2003, 162:1961-1974.
43. Juhan-Vague I., Alessi M.C. PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb Haemost 1997, 78:656-660.
44. Sawdey M.S., Loskutoff D.J. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. J Clin Invest 1991, 88:1346-1353.
45. Nguyen K.A., Cao Y., Chen J.R., Townsend C.M., Ko T.C. Dietary fiber enhances a tumor suppressor signaling pathway in the gut. Ann Surg 2006, 243:619-625. [discussion 25-7].
46. Mielczarek M., Chrzanowska A., Scibior D., Skwarek A., Ashamiss F., Lewandowska K., et al. Arginase as a useful factor for the diagnosis of colorectal cancer liver metastases. Int J Biol Markers 2006, 21:40-44.
47. Porembska Z., Nyckowski P., Skwarek A., Mielczarek M., Baranczyk-Kuzma A. Arginase a marker of cancerogenesis. II. Monitoring of patients after resection of colorectal liver metastases. Pol Merkur Lekarski 2002, 13:286-288.
48. Porembska Z., Skwarek A., Chrzanowska A., Mielczarek M., Nyckowski P., Baranczyk-Kuzma A. Arginase as a marker of cancerogenesis. III. Comparison of arginase activity with CEA and Ca 19-9 in liver metastases of colorectal cancer. Pol Merkur Lekarski 2004, 16:31-33.
49. Leu S.Y., Wang S.R. Clinical significance of arginase in colorectal cancer. Cancer 1992, 70:733-736.
50. Straus B., Cepelak I., Festa G. Arginase, a new marker of mammary carcinoma. Clin Chim Acta 1992, 210:5-12.
51. Ozer J., Ratner M., Shaw M., Bailey W., Schomaker S. The current state of serum biomarkers of hepatotoxicity. Toxicology 2008, 245:194-205.
52. Reifen R. Vitamin A as an anti-inflammatory agent. Proc Nutr Soc 2002, 61:397-400.
53. Johnson T.E. Recent results: biomarkers of aging. Exp Gerontol 2006, 41:1243-1246.
54. Huang H., Patel D.D., Manton K.G. The immune system in aging: roles of cytokines, T cells and NK cells. Front Biosci 2005, 10:192-215.
55. Wu D., Ren Z., Pae M., Guo W., Cui X., Merrill A.H., et al. Aging up-regulates expression of inflammatory mediators in mouse adipose tissue. J Immunol 2007, 179:4829-4839.
56. Abraham J., Campbell C.Y., Cheema A., Gluckman T.J., Blumenthal R.S., Danyi P. C-reactive protein in cardiovascular risk assessment: a review of the evidence. J Cardiometab Syndr 2007, 2:119-123.
57. Pan X., Hussain M.M. Clock is important for food and circadian regulation of macronutrient absorption in mice. J Lipid Res 2009, 50:1800-1813.
58. Stephan F.K. The "other" circadian system: food as a Zeitgeber. J Biol Rhythms 2002, 17:284-292.
59. Stephan F.K., Swann J.M., Sisk C.L. Anticipation of 24-hr feeding schedules in rats with lesions of the suprachiasmatic nucleus. Behav Neural Biol 1979, 25:346-363.
60. Mistlberger R.E. Circadian food-anticipatory activity: formal models and physiological mechanisms. Neurosci Biobehav Rev 1994, 18:171-195.
61. Hara R., Wan K., Wakamatsu H., Aida R., Moriya T., Akiyama M., et al. Restricted feeding entrains liver clock without participation of the suprachiasmatic nucleus. Genes Cells 2001, 6:269-278.
62. Oishi K., Miyazaki K., Ishida N. Functional CLOCK is not involved in the entrainment of peripheral clocks to the restricted feeding: entrainable expression of mPer2 and BMAL1 mRNAs in the heart of Clock mutant mice on Jcl:ICR background. Biochem Biophys Res Commun 2002, 298:198-202.
63. Horikawa K., Minami Y., Iijima M., Akiyama M., Shibata S. Rapid damping of food-entrained circadian rhythm of clock gene expression in clock-defective peripheral tissues under fasting conditions. Neuroscience 2005, 134:335-343.
64. Simonson M.S. Anti-AP-1 activity of all-trans retinoic acid in glomerular mesangial cells. Am J Physiol 1994, 267:F805-815.
65. Na S.Y., Kang B.Y., Chung S.W., Han S.J., Ma X., Trinchieri G., et al. Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB. J Biol Chem 1999, 274:7674-7680.
66. Chakravarti D., LaMorte V.J., Nelson M.C., Nakajima T., Schulman I.G., Juguilon H., et al. Role of CBP/P300 in nuclear receptor signalling. Nature 1996, 383:99-103.
67. Nozaki Y., Yamagata T., Sugiyama M., Ikoma S., Kinoshita K., Funauchi M. Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis. Clin Immunol 2006, 119:272-279.
68. Heliovaara M.K., Remitz A., Reitamo S., Teppo A.M., Karonen S.L., Ebeling P. 13-cis-Retinoic acid therapy induces insulin resistance, regulates inflammatory parameters, and paradoxically increases serum adiponectin concentration. Metabolism 2007, 56:786-791.
69. Takai K., Okuno M., Yasuda I., Matsushima-Nishiwaki R., Uematsu T., Tsurumi H., et al. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data. Intervirology 2005, 48:39-45.
70. Yamada Y., Shidoji Y., Fukutomi Y., Ishikawa T., Kaneko T., Nakagama H., et al. Positive and negative regulations of albumin gene expression by retinoids in human hepatoma cell lines. Mol Carcinog 1994, 10:151-158.
71. Yasuda I., Shiratori Y., Adachi S., Obora A., Takemura M., Okuno M., et al. Acyclic retinoid induces partial differentiation, down-regulates telomerase reverse transcriptase mRNA expression and telomerase activity, and induces apoptosis in human hepatoma-derived cell lines. J Hepatol 2002, 36:660-671.
72. Zhang N., Ahsan M.H., Zhu L., Sambucetti L.C., Purchio A.F., West D.B. NF-kappaB and not the MAPK signaling pathway regulates GADD45beta expression during acute inflammation. J Biol Chem 2005, 280:21400-21408.
73. Sherman H., Frumin I., Gutman R., Chapnik N., Lorentz A., Meylan J., et al. Long-term restricted feeding alters circadian expression and reduces the level of inflammatory and disease markers. J Cell Mol Med 2010, in press.
74. Ibrahim W.H., Habib H.M., Jarrar A.H., Al Baz S.A. Effect of Ramadan fasting on markers of oxidative stress and serum biochemical markers of cellular damage in healthy subjects. Ann Nutr Metab 2008, 53:175-181.